|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Azulfidine EN-tabs (sulfasalazine) Tablets, 500 mg, Pharmacia & Upjohn NDA 21-243 8/18/00 7/18/01 7/18/01 7/18/01 Azulfidine Indications: for the treatment of pediatric patients with polyarticular course juvenile rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs. Azulfidine EN-tabs (sulfasalazine) Tablets, 500 mg, Pharmacia & Upjohn NDA 7-073/S-120 7/30/02 8/6/02 Azulfidine EN-tabs (sulfasalazine) Tablets, 500 mg, Pharmacia & Upjohn NDA 7-073/S-115 Sulfasalazine Delayed-Release Tablets, 500 mg, Sulfasalazine Delayed-Release Tablets, Vintage ANDA 75-339 1/11/02 Sulfasalazine Tablets, 500 mg, Vintage ANDA 40-349 SULFASALAZINE Suspension; 250MG/5ML AZULFIDINE PHARMACIA AND UPJOHN 007073 SULFASALAZINE Tablet, Delayed Release; 500MG AZULFIDINE EN-TABS PHARMACIA AND UPJOHN 075339 SULFASALAZINE Tablet, Delayed Release; 500MG SULFASALAZINE Vintage 089590 SULFASALAZINE Tablet; 500MG SULFASALAZINE Mutual 007073 SULFASALAZINE Tablet; 500MG AZULFIDINE PHARMACIA AND UPJOHN 040349 SULFASALAZINE Tablet; 500MG SULFASALAZINE Vintage 085828 SULFASALAZINE Tablet; 500MG SULFASALAZINE Watson 087197 SULFASALAZINE Tablet; 500MG SULFASALAZINE Watson
|